Synergy Vaccines, Inc. Founded in 1998 Developing a Novel Vaccine Delivery/Adjuvant System Based on Technology Originating in the Duke University Laboratories of Dr. Salvatore V. Pizzo Has an Exclusive, Worldwide License to SynerVax™ Adjuvant Technology Developing Our Own Proprietary Vaccines Utilizing SynerVax™ Adjuvant Outlicensing SynerVax™ Adjuvant for Use with Clients' Vaccines

Richard M. Mueller Chairman and CEO Salvatore V. Pizzo, M.D., Ph.D. Chief Scientific Officer George J. Cianciolo, Ph.D. Vice President of Research